Active ingredient
Primidone
44 finished FDA listings contain Primidone as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- PRIMIDONE
- Dosage forms
- Tablet
- Routes
- Oral
- Manufacturers / labelers
- 22
- Strengths listed
- 125 mg/1 · 250 mg/1 · 50 mg/1
- Brand names in FDA listings
- Mysoline
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 8691
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 009170 | VALEANT | 1954-03-08 | 2 |
| ANDA 084903 | LANNETT | 1978-12-01 | 8 |
| ANDA 083551 | WATSON LABS | 1979-02-07 | 1 |
| ANDA 040586 | OXFORD PHARMS | 2005-02-24 | 13 |
| ANDA 040866 | AMNEAL PHARM | 2008-04-23 | 10 |
| ANDA 040862 | CHARTWELL RX | 2008-10-03 | 2 |
| ANDA 214896 | RUBICON RESEARCH | 2022-06-28 | 6 |
| ANDA 218366 | CARNEGIE | 2024-01-23 | 2 |
Official labeling on DailyMed
- MYSOLINE (PRIMIDONE) TABLET [BAUSCH HEALTH US, LLC] · version 11 · 2026-09-11
- PRIMIDONE TABLET [NCS HEALTHCARE OF KY, LLC DBA VANGARD LABS] · version 1 · 2026-09-02
- PRIMIDONE TABLET [ACTAVIS PHARMA, INC.] · version 21 · 2026-08-20
- PRIMIDONE TABLET [NCS HEALTHCARE OF KY, LLC DBA VANGARD LABS] · version 4 · 2026-07-02
- PRIMIDONE TABLET [BRYANT RANCH PREPACK] · version 6 · 2026-06-26
- PRIMIDONE TABLET [AVKARE] · version 11 · 2026-05-15
- PRIMIDONE TABLET [AMNEAL PHARMACEUTICALS OF NEW YORK LLC] · version 11 · 2026-04-10
- PRIMIDONE TABLET [PROFICIENT RX LP] · version 1 · 2026-01-16
- PRIMIDONE TABLET [ADVAGEN PHARMA LIMITED] · version 3 · 2026-01-14
- PRIMIDONE TABLET [CHARTWELL RX, LLC] · version 2 · 2025-12-12
- PRIMIDONE TABLET [PD-RX PHARMACEUTICALS, INC.] · version 19 · 2025-11-17
- PRIMIDONE TABLET [AVPAK] · version 14 · 2025-11-17
Showing the 12 most recent of 27 labels.
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.